Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Bevacizumab formulations with lower aggregation propensity, comprising corticosteroid anti-inflammatory drugs

Bevacizumab formulations with lower aggregation propensity, comprising corticosteroid anti-inflammatory drugs

US Patent 9155745 · Granted Oct 13, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Polylactide compositions and uses thereof2019
Protein sustained-release injectable formulation2018
Polylactide compositions and uses thereof2018
Protein sustained-release injectable formulation2018
Compositions comprising polymers prepared from 2-hydroxyalkyl acids2017
Hybrid hydrogels2016
Polylactide compositions and uses thereof2016
Product for use in agriculture or horticulture2015
Thermosetting neutralized chitosan composition forming a hydrogel, lyophilizate,2015
Pseudo-thermosetting neutralized chitosan composition forming a hydrogel and a p2014
Fatty acid derivative-polymer conjugate2014
Polylactides compositions and uses thereof2014